TNF-alpha: Roles in pathogenesis and therapeutics in cancer
Top Cited Papers
Open Access
- 4 February 2026
- journal article
- review article
- Published by Elsevier in Journal of Biological Chemistry
- Vol. 302 (3) , 111251
Abstract
No abstract availableKeywords
Funding Information
- National Institutes of Health
- Hyundai Hope On Wheels
- National Cancer Institute (K08 CA241088)
- National Cancer Institute (R37 CA289813)
This publication has 120 references indexed in Scilit:
- Tumor necrosis factor‐alpha inhibitors and risk of non‐Hodgkin lymphoma in a cohort of adults with rheumatologic conditionsInternational Journal of Cancer, 2018
- Tumor necrosis factor α inhibitor therapy and cancer risk in chronic immune‐mediated diseasesArthritis & Rheumatism, 2012
- TLR1/2, TLR7, and TLR9 Signals Directly Activate Human Peripheral Blood Naive and Memory B Cell Subsets to Produce Cytokines, Chemokines, and Hematopoietic Growth FactorsJournal of Clinical Immunology, 2010
- TNF? and the TNF receptor superfamily: Structure-function relationship(s)Microscopy Research and Technique, 2000
- The progressive differentiation of primed T cells is associated with an increasing susceptibility to apoptosisEuropean Journal of Immunology, 1994
- A randomised phase II study of carmustine alone or in combination with tomour necrosis factor in patients with advanced melanomaCancer Chemotherapy and Pharmacology, 1992
- A Southwest Oncology Group phase II trial of recombinant tumor necrosis factor in metastatic breast cancerCancer, 1991
- A phase II trial of recombinant tumor necrosis factor in patients with advanced colorectal carcinomaCancer, 1990
- Phase II clinical trial of high-dose recombinant human tumor necrosis factorCancer Chemotherapy and Pharmacology, 1989
- Antitumor activity of murine tumor necrosis factor (TNF) against transplanted murine tumors and heterotransplanted human tumors in nude miceInternational Journal of Cancer, 1984